14.06.2015 Views

Report on the Drug Situation 2010 - Bundesministerium für ...

Report on the Drug Situation 2010 - Bundesministerium für ...

Report on the Drug Situation 2010 - Bundesministerium für ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Table A26<br />

Pers<strong>on</strong>s starting drug treatment or requiring addicti<strong>on</strong> services in 2009, by primary<br />

drug and gender; percentages<br />

Primary drug<br />

(multiple indicati<strong>on</strong>s<br />

admissible)<br />

Short-term c<strong>on</strong>tacts Low-threshold L<strong>on</strong>g-term outpatient L<strong>on</strong>g-term inpatient<br />

services<br />

treatment<br />

treatment<br />

Gender Gender Gender Gender<br />

M F Total M F Total M F Total M F Total<br />

Opioids 38 47 40 53 56 54 54 62 56 79 84 80<br />

Heroin 27 34 28 35 33 35 38 41 39 61 56 60<br />

Methad<strong>on</strong>e 2 4 3 2 0 1 6 7 6 13 13 13<br />

O<strong>the</strong>r substituti<strong>on</strong><br />

substances<br />

O<strong>the</strong>r opioids, or opioids<br />

not specified<br />

13 17 14 25 26 25 22 28 24 40 50 42<br />

1 1 1 1 1 1 3 3 3 3 3 3<br />

Cocaine group 9 9 9 14 10 13 12 9 11 22 16 20<br />

Cocaine 8 9 9 14 10 13 12 8 11 22 16 20<br />

Crack 0 0 0 0 0 0 0 0 0 0 0 0<br />

Cocaine not specified 0 0 0 0 0 0 0 0 0 0 0 0<br />

Stimulants 2 3 3 1 2 1 4 3 3 8 6 8<br />

Amphetamines (e.g., speed) 2 2 2 1 1 1 3 2 3 7 5 6<br />

MDMA (ecstasy), o<strong>the</strong>r<br />

derivatives<br />

1 1 1 0 1 1 2 1 2 5 3 4<br />

Stimulants not specified 0 0 0 0 0 0 0 0 0 0 1 0<br />

Tranquillisers/hypnotics 9 12 10 15 12 14 10 14 11 20 27 22<br />

Benzodiazepines 9 11 9 15 12 14 10 13 11 20 27 22<br />

Barbiturates 0 0 0 0 0 0 0 0 0 0 0 0<br />

O<strong>the</strong>r hypnotics/<br />

tranquillisers<br />

0 1 0 0 1 0 0 0 0 0 1 0<br />

Hallucinogenic 0 1 0 0 0 0 1 0 1 2 1 2<br />

Hallucinogenic drugs not<br />

specified<br />

LSD 0 1 0 0 0 0 1 0 1 2 1 2<br />

0 0 0 0 0 0 0 0 0 0 0 0<br />

Cannabis 32 23 30 20 20 20 36 26 34 24 18 22<br />

Solvents and inhalants 0 0 0 1 0 1 0 0 0 0 0 0<br />

Alcohol 7 6 6 6 5 6 5 5 5 8 8 8<br />

Biogenic drugs 0 0 0 0 0 0 0 0 0 1 0 1<br />

Only use not relevant for<br />

treatment<br />

O<strong>the</strong>r drugs 0 0 0 0 0 0 0 0 0 1 0 0<br />

24 23 24 10 13 11 4 4 4 1 1 1<br />

Additi<strong>on</strong>al drug <strong>on</strong>ly 4 3 4 9 6 8 9 9 9 5 4 4<br />

Valid indicati<strong>on</strong>s 5 693 1 605 7 298 602 200 802 4 056 1 333 5 389 2 380 731 3 111<br />

Number of pers<strong>on</strong>s with<br />

valid indicati<strong>on</strong>s<br />

4 325 1 188 5 513 427 153 580 2 709 882 3 591 1 121 355 1 476<br />

Unknown 487 130 617 45 25 70 229 95 324 74 25 99<br />

Missing 73 30 103 10 3 13 210 62 272 65 22 87<br />

Note: All lines except Valid indicati<strong>on</strong>s, Unknown and Missing give percentages that relate to <strong>the</strong> number of<br />

valid indicati<strong>on</strong>s. Unknown means that <strong>the</strong> field ‘unknown’ was indicated and Missing means that no indicati<strong>on</strong><br />

was made.<br />

Bold type indicates main categories.<br />

Sampled populati<strong>on</strong>: all clients.<br />

Source: GÖG/ÖBIG <strong>2010</strong>a, DOKLI analysis of client year 2009<br />

Annex A 163

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!